CONTACT: LORELEI FLANIGAN
2130 Medical Laboratories
Iowa City IA 52242
(319) 335-9585; fax (319) 335-8034
Release: April 23, 1999
Asthma study focuses on environmentally friendly delivery
of investigational drug
IOWA CITY, Iowa -- A 14-week asthma study will begin soon
at the University of Iowa to test the safety and effectiveness of how an investigational
drug is delivered to a patient's lungs.
The combination drug of salmeterol/fluticasone propionate
will be compared with the same drugs individually as well as with an inactive
substance. All of the drugs will be given by metered dose inhalers (MDIs)
with a propellant that does not contain chlorofluorocarbons (CFCs). Most asthma
medications in MDIs use a propellant containing CFCs, which have been found
to be harmful to the environment.
Study participants will make up to 10 visits to the UI
Hospitals and Clinics for evaluation. Compensation is available.
For more information, contact Suzie Quinn at (319) 356-1659
or (800) 356-1659.